A quantitative structure - Activity relationship for the modulation effects of flavonoids on P-glycoprotein-mediated transport

Chemical and Pharmaceutical Bulletin

Volumn 58, Issue 9, 2010, Pages 1187-1194

  Sheu, Ming Thau ^a   Liou, Yi Bo ^a   Kao, Yu Han ^a   Lin, Ying Ku ^a   Ho, Hsiu O ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Fexofenadine; Flavonoid; Multidrug resistance; P glycoprotein; Quantitative structure activity relationship

Indexed keywords

ACACETIN; APIGENIN; AURANTIIN; BAICALEIN; DAIDZEIN; DIOSMIN; ERIODICTYOL; FEXOFENADINE; FISETIN; FLAVANOL DERIVATIVE; FLAVANONE; FLAVONE; FLAVONOL DERIVATIVE; FORMONONETIN; GALANGIN; GENISTEIN; GLYCOPROTEIN P; HESPERETIN; HESPERIDIN; ISOFLAVONE DERIVATIVE; ISOQUERCITRIN; KAEMPFEROL; LUTEOLIN; MORIN; MYRICETIN; NARINGENIN; QUERCETIN; TAXIFOLIN; VERAPAMIL;

ARTICLE; CANCER CELL CULTURE; COLORECTAL CARCINOMA; DRUG ACTIVITY; DRUG EFFECT; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; STRUCTURE ACTIVITY RELATION;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLAVONOIDS; HUMANS; P-GLYCOPROTEIN; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RABBITS; TERFENADINE;

EID: 77956304287     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.58.1187     Document Type: Article

References (19)

1. Ambudkar S. V., Dey S., Hrycyna C. A., Ramachandra M., Pastan I., Gottesman M. M., Annu. Rev. Pharmacol. Toxicol., 39, 361-398 (1999).
2. Teodor E., Dei S., Martelli C., Scapecchi S., Gualtieri F., Curr. Drug Targets, 7, 893-909 (2006).
3. Callaghan R., Ford R. C., Kerr I. D., FEBS Lett., 580, 1056-1063 (2006).
4. Lin J. H., Yamazaki M., Clin. Pharmacokinet., 42, 59-98 (2003).
5. Harborne J. B., Prog. Clin. Biol. Res., 213, 15-24 (1986).
6. Scalbert A., Manach C., Morand C., Remesy C., Jimenez L., Crit. Rev. Food Sci. Nutr., 45, 287-306 (2005).
7. Critchfield J.W., Welsh C. J., Phang J. M., Yeh G. C., Biochem. Phar- macol., 48, 1437-1445 (1994).
8. Zhang S., Morris M. E., J. Pharmacol. Exp. Ther., 304, 1258-1267 (2003).
9. Lo A., Burckart G. J., J. Clin. Pharmacol., 39, 995-1005 (1999).
10. Conseil G., Baubichon-Cortay H., Dayan G., Jault J. M., Barron D., Di Pietro A., Proc. Natl. Acad. Sci. U.S.A., 95, 9831-9836 (1998).
11. Pérez-Victoria J. M., Chiquero M. J., Conseil G., Dayan G., Di Pietro A., Barron D., Castanys S., Gamarro F., Biochemistry, 38, 1736-1743 (1999).
12. Di Pietro A., Conseil G., Pérez-Victoria J. M., Dayan G., Baubichon- Cortay H., Trompier D., Steinfels E., Jault J. M., de Wet H., Maitrejean M., Comte G., Boumendjel A., Mariotte A. M., Dumontet C., McIntosh D. B., Goffeau A., Castanys S., Gamarro F., Barron D., Cell Mol. Life Sci., 59, 307-322 (2002).
13. Boumendjel A., Di Pietro A., Dumontet C., Barron D., Med. Res. Rev., 22, 512-529 (2002).
14. Conseil G., Decottignies A., Jault J. M., Comte G., Barron D., Goffeau A., Di Pietro A., Biochemistry, 39, 6910-6917 (2003).
15. Kitagawa S., Biol. Pharm. Bull., 29, 1-6 (2006).
16. Boccard J., Bajot F., Di Pietro A., Rudaz S., Boumendjel A., Nicolle E., Carrupt P. A., Eur. J. Pharm Sci., 36, 254-264 (2009).
17. James K. C., "Solubility and Related Properties," Marcel Dekker, New York, 1986.
18. Nakumura T., Sakaeda T., Ohmoto N., Moriya Y., Komoto C., Shirakawa T., Gotoh A., Matsuo M., Okmura K., Pharm. Res., 20, 324-327 (2003).
19. Yue G. G., Yip T. W., Huang Y., Ko W. H., J. Biol. Chem., 79, 39310-39316 (2004).